Nektar Therapeutics
NKTR
NKTR
193 hedge funds and large institutions have $121M invested in Nektar Therapeutics in 2023 Q1 according to their latest regulatory filings, with 20 funds opening new positions, 56 increasing their positions, 67 reducing their positions, and 38 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more ownership
Funds ownership: →
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
47% less first-time investments, than exits
New positions opened: 20 | Existing positions closed: 38
68% less capital invested
Capital invested by funds: $376M → $121M (-$255M)
Holders
193
Holding in Top 10
–
Calls
$465K
Puts
$8K
Top Buyers
| 1 | +$2.03M | |
| 2 | +$1.8M | |
| 3 | +$1.53M | |
| 4 |
AQR Capital Management
Greenwich,
Connecticut
|
+$1.43M |
| 5 |
Two Sigma Advisers
New York
|
+$1.41M |
Top Sellers
| 1 | -$3.02M | |
| 2 | -$2.94M | |
| 3 | -$2.36M | |
| 4 |
B
Braidwell
Stamford,
Connecticut
|
-$1.4M |
| 5 |
CS
Candriam SCA
Strassen, Luxembourg,
Luxembourg
|
-$1.35M |